NON-SMALL CELL LUNG CANCER METASTATIC
Clinical trials for NON-SMALL CELL LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could 6 months of treatment match years? lung cancer trial challenges standard practice
Disease control CompletedThis study tested whether stopping immunotherapy after 6 months works as well as continuing it indefinitely for people with advanced lung cancer. Researchers enrolled 265 patients whose cancer had spread and who hadn't received prior treatment. After initial immunotherapy, half c…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE3 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Apr 04, 2026 00:51 UTC
-
Scientists test new Two-Drug attack on tough lung cancer
Disease control CompletedThis early-stage study tested a new drug, plinabulin, combined with an existing immunotherapy (nivolumab) for people with advanced non-small cell lung cancer that had worsened after chemotherapy. The main goal was to find the safest and most effective dose of the new combination.…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: Lyudmila Bazhenova, M.D. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test drug duo to outsmart resistant lung cancer
Disease control CompletedThis study tested whether adding the drug bevacizumab to standard treatment (osimertinib) could better control advanced non-small cell lung cancer that had developed a specific resistance mutation. It involved 155 adults whose cancer had progressed after initial targeted therapy.…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test safety of new Multi-Drug cocktails for tough cancers
Disease control CompletedThis early-stage study aimed to find safe doses for several different combinations of cancer drugs in patients with advanced or metastatic solid tumors, including lung cancer. The 60 participants were divided into groups to test combinations of chemotherapy, immunotherapy, and ta…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Blood test guides precision strikes against lingering lung cancer
Disease control CompletedThis study tested a new strategy for controlling advanced lung cancer that has spread. It aimed to see if using a sensitive blood test to detect tiny amounts of leftover cancer could guide doctors to use targeted radiation or surgery on the remaining tumors. The goal was to see i…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Precision radiation zaps tumors in advanced lung cancer trial
Disease control CompletedThis study tested whether adding a precise form of radiation therapy to standard targeted drug treatment could better control advanced lung cancer. It involved 27 people with stage IV non-small cell lung cancer driven by specific gene mutations who were already responding to thei…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC